TransMedics to Report Third Quarter 2019 Financial Results on November 6, 2019
ANDOVER, Mass., Oct. 16, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced …